pharmafocus_june_2018_cover

The June 2018 issue of Pharmafocus is now live!

pharmafile | May 31, 2018 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma 

The new June edition of Pharmafocus is now available to read online.

Following the much-publicised devastation it wrought in 2013 to 2016, the threat of Ebola is looming again, this time in the Democratic Republic of Congo in Central Africa. The WHO has authorised the use of experimental vaccine V920, with manufacturer MSD committing to provide more than 10,000 doses of the preventative therapy to the region. You can read the full story on our front page.

After more than a year of threats, President Trump’s action plan for cracking down on the pharmaceutical industry’s oftentimes predatory pricing practices, but the pledges have been found by some to be underwhelming – find out why on page 7.

Advertisement

In the UK, the news of Prime Minister Theresa May’s commitment to the use of AI to accelerate cancer diagnosis times and relieve the underfunded NHS comes as a step in the right direction, but how far will that commitment stretch in terms of actual funding? Find out the details on page 4.

And with the issue of data being a hot topic following the Facebook/Cambridge Analytica scandal and the advent of GDPR in Europe, don’t miss our in-depth feature on data management in the clinical space on page 22, or our special Market Access feature on the impact of Brexit on page 17.

Read the June edition of Pharmafocus online now!

Related Content

Pharma sees climate disruption as growing supply-chain risk

Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

The Gateway to Local Adoption Series

Latest content




Five Facts about COPD

October 11, 2026